Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-11-08

Clinical Trial Update: Prospective Study of Lymphoproliferative Diseases

View source ↗

Summary

This clinical trial update notes that the prospective study of lymphoproliferative diseases sponsored by West Virginia University has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: West Virginia University | Conditions: Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma | Status: WITHDRAWN